This three-day course is open to clinicians offering STI services. The curriculum includes didactic presentations by experienced faculty; 1/2 day of experiential training in laboratory techniques and, 1/2 day “hands-on” training in a directed sexual/reproductive health examination by genital teaching associates. Class size is limited to 8-10 participants. Continuing Education is provided Schedule – class schedule set annually. The cost for this class is $100.00
CME: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and STD/HIV Prevention Training Center at Johns Hopkins. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 18.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity provides 18 contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 1.9 CEU's for this program.
CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program is a designated event for pharmacists to receive 18.5 Contact Hours in pharmacy education. The Universal Activity Number is 0387-9999-16-071-L01-P.
Category: This activity has been designated as Knowledge-Based
For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 19 CPH recertification credits for this program.
CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.org.
CDC, our planners, our presenters (for enduring material, use “content experts” instead of “presenters”), and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Judy Wessell, DNP, FNP BC, ANP BC, ACRN, AACRN, AAHIVS and she wishes to disclose that she is on speakers bureua for ViiV, BMS, and Gilead. Dr. Richard Sterling would like to disclose that he is on advisory board for Gilead, Abbott/Abbvie, BMS, Vertex, Salix, Bayer. He also does research for Gilead, Abbott/Abbvie, Genentech, Merck, BMS, Vertex, Boehringer Ingelheim.
Presentations will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Rein’s discussion on the use of fluoroquinolones for M. genitalium and NGU. Also the future use of new combination therapies for GC being studied by CDC and data on incomplete HPV vaccine regimens and Gentamicin for GC. Also with the exception of Dr. Richard Sterling's discussion on Use of DAA in treating HCV.
CDC did not accept commercial support for this continuing education activity.
Jeanne Hoover 410-396-0621 Jeanne.Hoover@baltimorecity.gov